Protective effect of dried safflower petal aqueous extract and its main constituent, carthamus yellow, against lipopolysaccharide-induced inflammation in RAW264.7 macrophages

Journal of the Science of Food and Agriculture

Volumn 91, Issue 2, 2011, Pages 218-225

  Wang, Ching Chiung ^a   Choy, Cheuk Sing ^b,c,d   Liu, Yung Hung ^b   Cheah, Khoot Peng ^b   Li, Joe Sharg ^b   Wang, Jimmy Tse Jen ^b   Yu, Wen Yu ^b   Lin, Che Wei ^b   Cheng, Hui Wen ^a   Hu, Chien Ming ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d Zhongli Evergreen Hospital   (Taiwan)

Author keywords

Carthamus tinctorius L.; Carthamus yellow; Cyclooxygenase 2; Inducible nitric oxide synthase; Lipopolysaccharide; Safflower

Indexed keywords

AUTACOID; CARTHAMUS YELLOW; CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHENOL DERIVATIVE; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; FLOWER; INFLAMMATION; ISOLATION AND PURIFICATION; MACROPHAGE; METABOLISM; MOUSE; PHOSPHORYLATION; PHYTOTHERAPY; SAFFLOWER;

ANIMALS; CARTHAMUS TINCTORIUS; CYCLOOXYGENASE 2; FLOWERS; I-KAPPA B PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHENOLS; PHOSPHORYLATION; PHYTOTHERAPY; PLANT EXTRACTS;

ASTERACEAE; CARTHAMUS; CARTHAMUS TINCTORIUS;

EID: 78650207634     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.4172     Document Type: Article

References (50)

1. Kleinert H, Pautz A, Linker K Schwarz PM, Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500: 255-266 (2004).
2. Blantz RC Munger K, Role of nitric oxide in inflammatory conditions. Nephron 90: 3773-3378 (2002).
3. Harris SG, Padilla J, Koumas L, Ray D Phipps RP, Prostaglandins as modulators of immunity. Trends Immunol 23: 144-150 (2002).
4. Billack B, Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B. Am J Pharm Educ 70: 102 (2006).
5. Nomura Y, NF-κB activation and IκB: a dynamism involved in iNOS and chemokine induction in astroglial cells. Life Sci 68: 1695-1701 (2001).
6. Knowles PF Ashri A, Safflower: Carthamus tinctorius (Compositae), in Evolution of Crop Plants (2nd edn), ed. by Smartt J, Simmonds NW. Longman, Harlow, UK, pp. 47-50 (1995).
7. Wang G Li Y, Clinical application of safflower (Carthamus tinctorius). Zhejiang Trad Chin Med Sci J 20: 42-43 (1985).
8. Qi M, Li C, Lu H Liu W, Effects of some herbs on microcirculation of blood of rat's mesentery. J Chin Trad Med 25: 65-67 (1984).
9. Liu F, Yang XZ, Li FG, Hu J Cheng RF, Hypotensive effects of safflower yellow in spontaneously hypertensive rats and influence on plasma rennin activity and angiotensin II level. Acta Pharm Suec 27: 785-787 (1992).
10. Sun S, Studies on pharmacology of safflower and saffron crocus. J Chin Med Sci 5: 443-448 (1995).
11. Qi W, Zheng Y, Wei D, Zhang Y Yang J, Effects of safflower yellow pigment on the blood fat and liver function of rabbits. J Lanzh Coll Med Sci 3: 57-60 (1987).
12. Li C, Yan S, Zhao F Yan D, Effects of safflower on blood coagulation function of big rat. Trad Chin Med 14: 27-28 (1983).
13. Lu Y, Hu YL, Kong XF Wang DY, Selection of component drug in activating blood flow and removing blood stasis of Chinese herbal medicinal formula for dairy cow mastitis by hemorheological method. J Ethnopharmacol 116: 313-317 (2008).
14. Qin Y, An analysis on the clinical treatment of male sterility of 300 cases by kidney-benefited and invigorating blood-circulation decoction. Jiangxi Trad Chin Med 21: 21-22 (1990).
15. Qu C, Clinical observation on dead sperm excess disease of 182 cases. Shanghai Trad Chin Med J 5: 28-29 (1990).
16. Zheng Y, The treatment of thorax rheumatism of 800 cases with milkvetch-peach-safflower, etc. decoction. Liaoning Trad Chin Med Sci J 12: 19-20 (1998).
17. Tian J, Li G, Liu Z Fu F, Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action. Pharmacology 82: 121-126 (2008).
18. Ji DB, Zhang LY, Li CL, Ye J Zhu HB, Effect of hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia. Pharmacology 50: 137-145 (2009).
19. Ji DB, Zhu MC, Zhu B, Zhu YZ, Li CL, Ye J, et al, Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax. J Cardiovasc Pharmacol 52: 191-202 (2008).
20. Choy CS, Hu CM, Chiu WT, Lam CSK, Ting Y, Tsai SH, et al, Suppression of lipopolysaccharide-induced of inducible nitric oxide synthase and cyclooxygenase-2 by Sanguis Draconis, a dragon's blood resin, in RAW 264.7 cells. J Ethnopharmacol 115: 455-462 (2008).
21. Zuckerbraun HL, Babich H, May R Sinensky MC, Triclosan: cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro. Eur J Oral Sci 106: 628-636 (1998).
22. Hu CM, Liu YH, Cheah KP, Li JS, Lam CSK, Yu WY, et al, Heme oxygenase-1 mediates the inhibitory actions of brazilin in RAW264.7 macrophages stimulated with lipopolysaccharide. J Ethnopharmacol 121: 79-85 (2009).
23. Morimoto I, Watanabe F Osawa T, Okitsu T Kada T, Mutagenicity screening of crude drugs with Bacillus subtilis rec-assay and Salmonella/microsome reversion assay. Mutat Res 97: 81-102 (1982).
24. Yin XJ, Liu D, Wang H Zhou Y, A study on the mutagenicity of 102 raw pharmaceuticals used in Chinese traditional medicine. Mutat Res 260: 73-82 (1991).
25. Nobakht M, Fattahi M, Hoormand M, Milanian I, Rahbar N Mahmoudian M, A study on the teratogenic and cytotoxic effects of safflower extract. J Ethnopharmacol 73: 453-459 (2000).
26. McCann SM, Mastronardi C, Laurentiis A de Rettori V, The nitric oxide theory of aging revisited. Ann NY Acad Sci 1057: 64-84 (2005).
27. Jarrar D, Kuebler JF, Rue LW, Matalon S, Wang P, Bland KI, et al, Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kB and MAPK/ERK mechanisms. Am J Physiol Lung Cell Mol Physiol 283: L799-805 (2002).
28. 2 augments IL-10 signaling and function. J Immunol 15: 1092-1100 (2006).
29. Wolf AM, Wolf D, Rumpold H, Ludwiczek S, Enrich B, Gastl G, et al, The kinase inhibitor imatinib mesylate inhibits TNF-α production in vitro and prevents TNF-dependent acute hepatic inflammation. Proc Natl Acad Sci USA 20: 13622-13627 (2005).
30. Zhang G Ghosh S, Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res 6: 453-457 (2000).
31. Ghosh S Karin M, Missing pieces in the NF-κB puzzle. Cell 109: 81-96 (2002).
32. Baldwin ASJ, The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683 (1996).
33. Baeuerle PA, IκB-NF-κB structures: at the interface of inflammation control. Cell 95: 729-731 (1998).
34. Yen KY, An Illustrated Pharmacognosy. SMC Publishing, Taipei, p. 78 (1992).
35. Hiramatsu M, Takahashi T, Komatsu M, Kido T Kasahara Y, Antioxidant and neuroprotective activities of Mogami-benibana (safflower, Carthamus tinctorius Linne). Neurochem Res 34: 795-805 (2009).
36. Ye SY Gao WY, Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats. Arch Pharm Res 31: 1010-1015 (2008).
37. Chen TT, Du YJ, Liu XL Zhu HB, Inhibitory action of hydroxysafflor yellow A on inflammatory signal transduction pathway related factors in rats with cerebral cortex ischemia. Yao Xue Xue Bao 43: 570-575 (2008).
38. Zhu HB, Zhang L, Wang ZH, Tian JW, Fu FH, Liu K, et al, Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms. J Asian Nat Prod Res 7: 607-613 (2005).
39. Zhu HB, Wang ZH, Tian JW, Fu FH, Liu K Li CL, Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats. Yao Xue Xue Bao 40: 1144-1146 (2005).
40. Wei X, Liu H, Sun X, Fu F, Zhang X, Wang J, et al, Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci Lett 386: 58-62 (2005).
41. Zhu H, Wang Z, Ma C, Tian J, Fu F, Li C, et al, Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies. Planta Med 69: 429-433 (2003).
42. Wang C, Zhang D, Li G, Liu J, Tian J, Fu F, et al, Neuroprotective effects of safflor yellow B on brain ischemic injury. Exp Brain Res 177: 533-539 (2007).
43. Jin Y, Xu D Xu W, Influence of safflower injection on hemorheology of patients of chronic cor pulmonale during acute attack. Zhongguo Zhong Xi Yi Jie He Za Zhi 20: 430-432 (2000).
44. Zhang JC, Xia L Bai M, Changes of ICAM-1 and P-selectin in rats with pulmonary thromboembolism and the effect of safflower injection. Zhongguo Zhong Xi Yi Jie He Za Zhi 26: 629-632 (2006).
45. Piga R, Naito Y, Kokura S, Handa O Yoshikawa T, Inhibitory effect of serotonin derivatives on high glucose-induced adhesion and migration of monocytes on human aortic endothelial cells. Br J Nutr 102: 264-272 (2009).
46. Lu ZW, Liu F, Hu J, Bian D Li FG, Suppressive effects of safflower yellow on immune functions. Zhongguo Yao Li Xue Bao 12: 537-542 (1991).
47. Wakabayashi T, Hirokawa S, Yamauhi N, Kataoka T, Woo J-T Nagai K, Immunomodulating activities of polysaccharide fractions from dried safflower petals. Cytotechnology 25: 205-211 (1997).
48. Ando I, Tsukumo Y, Wakabayashi T, Akashi S, Miyake K, Kataoka T, et al, Safflower polysaccharides activate the transcription factor NF-κB via Toll-like receptor 4 and induce cytokine production by macrophages. Int Immunopharmacol 2: 1155-1162 (2002).
49. Fan L, Zhao HY, Xu M, Zhou L, Guo H, Han J, et al, Qualitative evaluation and quantitative determination of 10 major active components in Carthamus tinctorius L. by high-performance liquid chromatography coupled with diode array detector. J Chromatogr A 1216: 2063-2070 (2009).
50. Koyama N, Kuribayashi K, Seki T, Kobayashi K, Furuhata Y, Suzuki K, et al, Serotonin derivatives, major safflower (Carthamus tinctorius L.) seed antioxidants, inhibit low-density lipoprotein (LDL) oxidation and atherosclerosis in apolipoprotein E-deficient mice. J Agric Food Chem 54: 4970-4976 (2006).